These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 8296795)
41. Isoagglutinins following ABO-incompatible bone marrow transplantation. Wernet D; Mayer G Vox Sang; 1992; 62(3):176-9. PubMed ID: 1609520 [TBL] [Abstract][Full Text] [Related]
42. ABO-incompatible bone marrow transplantation: prevention of hemolysis by alkaline hydration with mannitol diuresis in conjunction with red cell reduced buffy coat bone marrow. Slavc I; Urban C; Schwinger W; Hauer C; Vadon M Wien Klin Wochenschr; 1992; 104(4):93-6. PubMed ID: 1570714 [TBL] [Abstract][Full Text] [Related]
43. Higher Anti-A/B isoagglutinin titers of IgG class, but not of IgM, are associated with increased red blood cell transfusion requirements in bone marrow transplantation with major ABO-mismatch. De Santis GC; Garcia-Silva AC; Dotoli GM; de Castro PT; Simões BP; Covas DT Clin Transplant; 2017 Apr; 31(4):. PubMed ID: 28160319 [TBL] [Abstract][Full Text] [Related]
44. Massive immune hemolysis after non-myeloablative allogeneic peripheral blood stem cell transplantation with minor ABO-incompatibility. Noborio K; Muroi K; Izumi T; Toshima M; Kawano-Yamamoto C; Otsuki T; Nagai T; Komatsu N; Ozawa K Leuk Lymphoma; 2003 Feb; 44(2):357-9. PubMed ID: 12688358 [TBL] [Abstract][Full Text] [Related]
45. Infusion hemolysis after pediatric major ABO-mismatched bone marrow transplant: Comparison of two red blood cell depletion techniques. Nickel RS; Qayed M; Worthington-White D; Stowell SR; Chiang KY Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29115715 [TBL] [Abstract][Full Text] [Related]
46. Plasma exchange and immunoadsorption for removal of antibodies prior to ABO incompatible bone marrow transplant. Bensinger WI Artif Organs; 1981 Aug; 5(3):254-8. PubMed ID: 7030280 [TBL] [Abstract][Full Text] [Related]
47. ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation. Benjamin RJ; McGurk S; Ralston MS; Churchill WH; Antin JH Transfusion; 1999 Feb; 39(2):179-87. PubMed ID: 10037129 [TBL] [Abstract][Full Text] [Related]
48. Case report: isoimmune inhibition of erythropoiesis following ABO-incompatible bone marrow transplantation. Sahovic EA; Flick J; Graham CD; Stuart RK Am J Med Sci; 1991 Dec; 302(6):369-73. PubMed ID: 1772122 [TBL] [Abstract][Full Text] [Related]
49. Transfusion of donor-type red cells as a single preparative treatment for bone marrow transplants with major ABO incompatibility. Nussbaumer W; Schwaighofer H; Gratwohl A; Kilga S; Schönitzer D; Nachbaur D; Niederwieser D Transfusion; 1995 Jul; 35(7):592-5. PubMed ID: 7631393 [TBL] [Abstract][Full Text] [Related]
50. Major ABO-incompatible hematopoietic stem cell transplantation: study of post-transplant pure red cell aplasia and endothelial cell chimerism. Mueller RJ; Stussi G; Odermatt B; Halter J; Schanz U; Seebach JD Xenotransplantation; 2006 Mar; 13(2):126-32. PubMed ID: 16623806 [TBL] [Abstract][Full Text] [Related]
51. Transplantation of major ABO-incompatible bone marrow depleted of red cells by hydroxyethyl starch. Warkentin PI; Hilden JM; Kersey JH; Ramsay NK; McCullough J Vox Sang; 1985; 48(2):89-104. PubMed ID: 2416122 [TBL] [Abstract][Full Text] [Related]
53. Passenger lymphocyte syndrome in ABO and Rhesus D minor mismatched liver and kidney transplantation: A prospective analysis. ElAnsary M; Hanna MO; Saadi G; ElShazly M; Fadel FI; Ahmed HA; Aziz AM; ElSharnouby A; Kandeel MM Hum Immunol; 2015 Jun; 76(6):447-52. PubMed ID: 25842056 [TBL] [Abstract][Full Text] [Related]
54. Exchange transfusion the hard way: massive hemolysis following transplantation of bone marrow with minor ABO incompatibility. Greeno EW; Perry EH; Ilstrup SJ; Weisdorf DJ Transfusion; 1996 Jan; 36(1):71-4. PubMed ID: 8607158 [TBL] [Abstract][Full Text] [Related]
55. Acute hemolysis after intravenous immunoglobulin amid host factors of ABO-mismatched bone marrow transplantation, inflammation, and activated mononuclear phagocytes. Michelis FV; Branch DR; Scovell I; Bloch E; Pendergrast J; Lipton JH; Cserti-Gazdewich CM Transfusion; 2014 Mar; 54(3):681-90. PubMed ID: 23829192 [TBL] [Abstract][Full Text] [Related]
56. Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation with recombinant erythropoietin. Heyll A; Aul C; Runde V; Arning M; Schneider W; Wernet P Blood; 1991 Feb; 77(4):906. PubMed ID: 1899624 [No Abstract] [Full Text] [Related]
57. Non-ABO red blood cell alloantibodies following allogeneic hematopoietic stem cell transplantation. Franchini M; Gandini G; Aprili G Bone Marrow Transplant; 2004 Jun; 33(12):1169-72. PubMed ID: 15094753 [TBL] [Abstract][Full Text] [Related]
58. [Prevention of ABO-incompatible transfusion]. Fujii Y Masui; 2011 Jan; 60(1):47-54. PubMed ID: 21348250 [TBL] [Abstract][Full Text] [Related]
59. Serological complications of a major ABO incompatible bone marrow transplantation in a Polynesian with aplastic anemia. Ockelford PA; Hill RS; Nelson L; Blacklock HA; Woodfield DG; Matthews JR Transfusion; 1982; 22(1):62-5. PubMed ID: 7039010 [TBL] [Abstract][Full Text] [Related]